CN102621325B - 用于检测血液中多西他赛浓度的试剂盒 - Google Patents
用于检测血液中多西他赛浓度的试剂盒 Download PDFInfo
- Publication number
- CN102621325B CN102621325B CN201210099620.6A CN201210099620A CN102621325B CN 102621325 B CN102621325 B CN 102621325B CN 201210099620 A CN201210099620 A CN 201210099620A CN 102621325 B CN102621325 B CN 102621325B
- Authority
- CN
- China
- Prior art keywords
- docetaxel
- reagent
- concentration
- nano microsphere
- damping fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210099620.6A CN102621325B (zh) | 2012-04-06 | 2012-04-06 | 用于检测血液中多西他赛浓度的试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210099620.6A CN102621325B (zh) | 2012-04-06 | 2012-04-06 | 用于检测血液中多西他赛浓度的试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102621325A CN102621325A (zh) | 2012-08-01 |
CN102621325B true CN102621325B (zh) | 2014-11-12 |
Family
ID=46561363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210099620.6A Active CN102621325B (zh) | 2012-04-06 | 2012-04-06 | 用于检测血液中多西他赛浓度的试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102621325B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103344763A (zh) * | 2013-06-18 | 2013-10-09 | 华东师范大学 | 乳胶增强型afp检测试剂盒及其制备方法和应用 |
CN103454360B (zh) * | 2013-10-10 | 2015-07-22 | 中国医学科学院肿瘤医院 | 超滤联合uplc-ms/ms法测定人血浆中游离多西他赛浓度 |
CN106093373A (zh) * | 2016-05-27 | 2016-11-09 | 安徽伊普诺康生物技术股份有限公司 | 一种测定透明质酸的试剂盒 |
CN105954455A (zh) * | 2016-07-21 | 2016-09-21 | 中国科学院海洋研究所 | 一种多西紫杉醇含量的测定方法 |
CN111089915A (zh) * | 2019-11-15 | 2020-05-01 | 沈阳和合医学检验所有限公司 | 一种测定人血浆中多西他赛药物浓度的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006102200A2 (en) * | 2005-03-22 | 2006-09-28 | Saladax Biomedical Inc. | Docetaxel immunoassay |
CN101019024A (zh) * | 2004-07-29 | 2007-08-15 | 萨拉达克斯生物医疗公司 | 紫杉醇免疫测定法 |
CN101813700A (zh) * | 2010-03-31 | 2010-08-25 | 浙江伊利康生物技术有限公司 | 一种纳米微球免疫比浊法检测β2-微球蛋白试剂盒 |
CN102128924A (zh) * | 2010-01-12 | 2011-07-20 | 上海景源医疗器械有限公司 | 乳胶增强免疫比浊法测定尿液转铁蛋白试剂盒及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101347106B1 (ko) * | 2004-12-08 | 2014-01-02 | 아벤티스 파마슈티칼스 인크. | 도세탁셀에 대한 내성 또는 감수성을 측정하는 방법 |
-
2012
- 2012-04-06 CN CN201210099620.6A patent/CN102621325B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101019024A (zh) * | 2004-07-29 | 2007-08-15 | 萨拉达克斯生物医疗公司 | 紫杉醇免疫测定法 |
WO2006102200A2 (en) * | 2005-03-22 | 2006-09-28 | Saladax Biomedical Inc. | Docetaxel immunoassay |
CN102128924A (zh) * | 2010-01-12 | 2011-07-20 | 上海景源医疗器械有限公司 | 乳胶增强免疫比浊法测定尿液转铁蛋白试剂盒及其制备方法 |
CN101813700A (zh) * | 2010-03-31 | 2010-08-25 | 浙江伊利康生物技术有限公司 | 一种纳米微球免疫比浊法检测β2-微球蛋白试剂盒 |
Non-Patent Citations (3)
Title |
---|
Baker,SD et al..Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography tandem mass spectrometry.《Analytical Biochemistry》.2004,全文. * |
HPLC测定注射用多西他赛中多西他赛含量;王亚群等;《华西医学》;20080515;全文 * |
王亚群等.HPLC测定注射用多西他赛中多西他赛含量.《华西医学》.2008,全文. * |
Also Published As
Publication number | Publication date |
---|---|
CN102621325A (zh) | 2012-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102621325B (zh) | 用于检测血液中多西他赛浓度的试剂盒 | |
Hsieh et al. | Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes | |
Kinoh et al. | Translational nanomedicine boosts anti-PD1 therapy to eradicate orthotopic PTEN-negative glioblastoma | |
Guo et al. | Deliver anti-PD-L1 into brain by p-hydroxybenzoic acid to enhance immunotherapeutic effect for glioblastoma | |
CN101917982B (zh) | 使用4-碘-3-硝基苯甲酰胺与抗肿瘤剂组合治疗乳腺癌 | |
RU2013106938A (ru) | Биомаркеры в плазме крови, предназначенные для комбинированных терапий с использованием бевацизумаба при лечении рака молочной железы | |
Xu et al. | Disclosing targets and pharmacological mechanisms of total bioflavonoids extracted from Selaginella doederleinii against non-small cell lung cancer by combination of network pharmacology and proteomics | |
Dong et al. | Development and evaluation of new methods for protein quantification in dissolving microneedles formulations | |
Unsalan et al. | Therapeutic monitoring of isoniazid, pyrazinamide and rifampicin in tuberculosis patients using LC | |
Fujita et al. | A clinical pharmacokinetic microdosing study of docetaxel with Japanese patients with cancer | |
CN103163232B (zh) | 一种来那度胺及其制剂的含量测定和杂质测定的方法 | |
CN101721677B (zh) | 一种胸腺五肽口服微球制剂及其制备方法 | |
Park et al. | NDUFA12 As a functional target of the anticancer compound ertredin in human hepatoma cells as revealed by label-free chemical proteomics | |
Ji et al. | Quantification of orelabrutinib in human plasma and cerebrospinal fluid by liquid chromatography tandem mass spectrometry | |
CN104914101B (zh) | 一种长春新碱的elisa检测方法 | |
CN102928525A (zh) | 硫酸头孢匹罗/氯化钠注射液中的头孢匹罗有关物质ⅱ的检测方法 | |
CN105753881A (zh) | 一种提高青蒿素类药物生物利用度的方法 | |
Zhang et al. | The Anti-Hypoxia Protective Effect of WYY026B by Interacting with Hemoglobin in Red Blood Cells | |
Cooper et al. | A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemia | |
Shirao et al. | A phase I escalating single-dose and weekly fixed-dose study of cetuximab pharmacokinetics in Japanese patients with solid tumors | |
CN104730164A (zh) | 一种美洲大蠊抗肿瘤活性提取物cⅱ-3的分子量检测方法 | |
Jia-xi et al. | The correlation between the plasma concentration of gemcitabine and short-term efficacy and adverse reactions in patients with advanced squamous cell carcinoma of the lung using liquid chromatography-mass spectrometry | |
CN106525987B (zh) | 一种奈达铂的杂质检测方法 | |
Zhang et al. | Safety, tolerability, and pharmacokinetics of mitoxantrone hydrochloride injection for tracing in patients with gastric cancer: a single-blind, single-center, phase I clinical trial | |
CN104215703B (zh) | 一种注射用益气复脉中糖苷类大分子物质的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 201100 Shanghai East Road, Minhang District, No. 85 Patentee after: SHANGHAI AILEX TECHNOLOGY Co.,Ltd. Address before: 201100 Shanghai East Road, Minhang District, No. 85 Patentee before: SHANGHAI AILEX TECHNOLOGY Co.,Ltd. |
|
CP03 | Change of name, title or address |
Address after: 201108 Lane 152, 468, Beihengsha River Road, Minhang District, Shanghai Patentee after: AILEX TECHNOLOGY GROUP Co.,Ltd. Address before: No. 85 Youdong Road, Minhang District, Shanghai 201100 Patentee before: SHANGHAI AILEX TECHNOLOGY Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181211 Address after: 201108 Lane 152, 468, Beihengsha River Road, Minhang District, Shanghai Co-patentee after: ZHEJIANG AILEX MEDICAL Co.,Ltd. Patentee after: AILEX TECHNOLOGY GROUP Co.,Ltd. Address before: 201108 Lane 152, 468, Beihengsha River Road, Minhang District, Shanghai Patentee before: AILEX TECHNOLOGY GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right |